Your session is about to expire
← Back to Search
Prebiotic Fiber Supplementation for Gut Health
Study Summary
This trial will study how changes in gut bacteria relate to prebiotic fiber supplementation in order to develop a biological signature for the effect of these supplements on the body.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You drink a lot of alcohol regularly.I am in good overall health.I am taking medication that affects my sugar or fat metabolism.I have a condition affecting my blood vessels.I have had weight loss surgery in the past.You currently have an active eating disorder.I have a long-term inflammatory condition.My high blood pressure is not under control.You have a current mental illness that requires treatment.I do not have any major organ disease.
- Group 1: ARM 1: Arabinoxylan, Beta-Glucan, Resistant Starch, Inulin
- Group 2: ARM 23: Inulin, Arabinoxylan, Beta-Glucan, Resistant Starch
- Group 3: ARM 7: Beta-Glucan, Arabinoxylan, Resistant Starch, Inulin
- Group 4: ARM 24: Inulin, Arabinoxylan, Resistant Starch, Beta-Glucan
- Group 5: ARM 11: Beta-Glucan, Inulin, Arabinoxylan, Resistant Starch
- Group 6: ARM 14: Resistant Starch, Inulin, Arabinoxylan, Beta-Glucan
- Group 7: ARM 19: Inulin, Resistant Starch, Arabinoxylan, Beta-Glucan
- Group 8: ARM 8: Beta-Glucan, Arabinoxylan, Inulin, Resistant Starch
- Group 9: ARM 20: Inulin, Resistant Starch, Beta-Glucan, Arabinoxylan
- Group 10: ARM 22: Inulin, Beta-Glucan, Arabinoxylan, Resistant Starch
- Group 11: ARM 12: Beta-Glucan, Inulin, Resistant Starch, Arabinoxylan
- Group 12: ARM 5: Arabinoxylan, Inulin, Beta-Glucan, Resistant Starch
- Group 13: ARM 18: Resistant Starch, Beta-Glucan, Arabinoxylan, Inulin
- Group 14: ARM 10: Beta-Glucan, Resistant Starch, Arabinoxylan, Inulin
- Group 15: ARM 3: Arabinoxylan, Resistant Starch, Beta-Glucan, Inulin
- Group 16: ARM 2: Arabinoxylan, Beta-Glucan, Inulin, Resistant Starch
- Group 17: ARM 21: Inulin, Beta-Glucan, Resistant Starch, Arabinoxylan
- Group 18: ARM 16: Resistant Starch, Arabinoxylan, Beta-Glucan, Inulin
- Group 19: ARM 6: Arabinoxylan, Inulin, Resistant Starch, Beta-Glucan
- Group 20: ARM 9: Beta-Glucan, Resistant Starch, Inulin, Arabinoxylan
- Group 21: ARM 4: Arabinoxylan, Resistant Starch, Inulin, Beta-Glucan
- Group 22: ARM 13: Resistant Starch, Inulin, Beta-Glucan, Arabinoxylan
- Group 23: ARM 15: Resistant Starch, Arabinoxylan, Inulin, Beta-Glucan
- Group 24: ARM 17: Resistant Starch, Beta-Glucan, Inulin, Arabinoxylan
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must participants fulfill to join the experiment?
"This clinical investigation is seeking 20 volunteers, aged between 35 and 65 years old, with prebiotics. Additionally, it is essential that these participants also showcase a good state of health."
Are individuals younger than 60 years of age eligible to participate in this experiment?
"This research is accepting patients aged 35 years or older, but under 65."
Are there any patient slots available in this research program?
"As indicated on clinicaltrials.gov, this trial is open to participants and actively accepting candidates. This particular medical study was posted in January of 2020 and its most recent alteration occurred May 21st 2021."
How many individuals are anticipated to be part of this medical experiment?
"Affirmative. Details on clinicaltrials.gov point to this medical trial, which was first shared on January 21st 2020, actively recruiting participants. The investigators need 20 individuals from one facility to take part in the study."
Share this study with friends
Copy Link
Messenger